Distal muscle weakness: Difference between revisions
Jump to navigation
Jump to search
Iqra Qamar (talk | contribs) No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
Differential diagnosis of | Differential diagnosis of distal muscle weakness: | ||
[[Dexamethasone suppression test|<nowiki/>]] | [[Dexamethasone suppression test|<nowiki/>]] | ||
Line 27: | Line 27: | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Electromyogram | ! style="background:#4479BA; color: #FFFFFF;" align="center" + |Electromyogram | ||
|- | |- | ||
!Endocrine | ! style="background:#4479BA; color: #FFFFFF;" align="center" + |Endocrine | ||
! style="background:#DCDCDC;" align="center" + |[[Hyperaldosteronism]] with myopathy<ref name="pmid5037033">{{cite journal |vauthors=Sambrook MA, Heron JR, Aber GM |title=Myopathy in association with primary hyperaldosteronism |journal=J. Neurol. Neurosurg. Psychiatry |volume=35 |issue=2 |pages=202–7 |date=April 1972 |pmid=5037033 |pmc=494037 |doi= |url=}}</ref> | ! style="background:#DCDCDC;" align="center" + |[[Hyperaldosteronism]] with myopathy<ref name="pmid5037033">{{cite journal |vauthors=Sambrook MA, Heron JR, Aber GM |title=Myopathy in association with primary hyperaldosteronism |journal=J. Neurol. Neurosurg. Psychiatry |volume=35 |issue=2 |pages=202–7 |date=April 1972 |pmid=5037033 |pmc=494037 |doi= |url=}}</ref> | ||
| style="background:#F5F5F5;" align="center" + |50 | | style="background:#F5F5F5;" align="center" + |50 | ||
Line 39: | Line 39: | ||
| style="background:#F5F5F5;" align="center" + |− | | style="background:#F5F5F5;" align="center" + |− | ||
| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki> | | style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki> | ||
[[Rhabdomyolysis]] | [[Rhabdomyolysis]] | ||
| style="background:#F5F5F5;" align="left" + | | | style="background:#F5F5F5;" align="left" + | | ||
Line 57: | Line 56: | ||
* Normal | * Normal | ||
|- | |- | ||
! rowspan="3" |Inflammatory/ Rheumatologic | ! rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" + |Inflammatory/ Rheumatologic | ||
! style="background:#DCDCDC;" align="center" + |Inclusion body [[myositis]]<ref name="pmid16586493">{{cite journal| author=Dalakas MC| title=Polymyositis, dermatomyositis and inclusion-body myositis. | journal=N Engl J Med | year= 1991 | volume= 325 | issue= 21 | pages= 1487-98 | pmid=1658649 | doi=10.1056/NEJM199111213252107 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1658649 }}</ref> | ! style="background:#DCDCDC;" align="center" + |Inclusion body [[myositis]]<ref name="pmid16586493">{{cite journal| author=Dalakas MC| title=Polymyositis, dermatomyositis and inclusion-body myositis. | journal=N Engl J Med | year= 1991 | volume= 325 | issue= 21 | pages= 1487-98 | pmid=1658649 | doi=10.1056/NEJM199111213252107 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1658649 }}</ref> | ||
| style="background:#F5F5F5;" align="center" + |50s | | style="background:#F5F5F5;" align="center" + |50s | ||
Line 145: | Line 144: | ||
* Normal | * Normal | ||
|- | |- | ||
!Genetic | ! style="background:#4479BA; color: #FFFFFF;" align="center" + |Genetic | ||
| style="background:#DCDCDC;" align="center" + |[[Myotonic dystrophy]]<ref name="pmid22995693">{{cite journal |vauthors=Udd B, Krahe R |title=The myotonic dystrophies: molecular, clinical, and therapeutic challenges |journal=Lancet Neurol |volume=11 |issue=10 |pages=891–905 |date=October 2012 |pmid=22995693 |doi=10.1016/S1474-4422(12)70204-1 |url=}}</ref> | | style="background:#DCDCDC;" align="center" + |[[Myotonic dystrophy]]<ref name="pmid22995693">{{cite journal |vauthors=Udd B, Krahe R |title=The myotonic dystrophies: molecular, clinical, and therapeutic challenges |journal=Lancet Neurol |volume=11 |issue=10 |pages=891–905 |date=October 2012 |pmid=22995693 |doi=10.1016/S1474-4422(12)70204-1 |url=}}</ref> | ||
| style="background:#F5F5F5;" align="center" + |<18 years | | style="background:#F5F5F5;" align="center" + |<18 years | ||
Line 200: | Line 199: | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Electromyogram | ! style="background:#4479BA; color: #FFFFFF;" align="center" + |Electromyogram | ||
|- | |- | ||
! rowspan="2" |Infectious | ! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Infectious | ||
! style="background:#DCDCDC;" align="center" + |[[Influenza]]<ref name="pmid6687269">{{cite journal |vauthors=Bove KE, Hilton PK, Partin J, Farrell MK |title=Morphology of acute myopathy associated with influenza B infection |journal=Pediatr Pathol |volume=1 |issue=1 |pages=51–66 |date=1983 |pmid=6687269 |doi= |url=}}</ref> | ! style="background:#DCDCDC;" align="center" + |[[Influenza]]<ref name="pmid6687269">{{cite journal |vauthors=Bove KE, Hilton PK, Partin J, Farrell MK |title=Morphology of acute myopathy associated with influenza B infection |journal=Pediatr Pathol |volume=1 |issue=1 |pages=51–66 |date=1983 |pmid=6687269 |doi= |url=}}</ref> | ||
| style="background:#F5F5F5;" align="center" + |Variable | | style="background:#F5F5F5;" align="center" + |Variable | ||
Line 283: | Line 282: | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Electromyogram | ! style="background:#4479BA; color: #FFFFFF;" align="center" + |Electromyogram | ||
|- | |- | ||
! rowspan="3" style="background:# | ! rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" + |Neurologic | ||
! style="background:#DCDCDC;" align="center" + |[[Amyotrophic lateral sclerosis|ALS]]<ref name="pmid26629397">{{cite journal |vauthors=Zarei S, Carr K, Reiley L, Diaz K, Guerra O, Altamirano PF, Pagani W, Lodin D, Orozco G, Chinea A |title=A comprehensive review of amyotrophic lateral sclerosis |journal=Surg Neurol Int |volume=6 |issue= |pages=171 |date=2015 |pmid=26629397 |pmc=4653353 |doi=10.4103/2152-7806.169561 |url=}}</ref> | ! style="background:#DCDCDC;" align="center" + |[[Amyotrophic lateral sclerosis|ALS]]<ref name="pmid26629397">{{cite journal |vauthors=Zarei S, Carr K, Reiley L, Diaz K, Guerra O, Altamirano PF, Pagani W, Lodin D, Orozco G, Chinea A |title=A comprehensive review of amyotrophic lateral sclerosis |journal=Surg Neurol Int |volume=6 |issue= |pages=171 |date=2015 |pmid=26629397 |pmc=4653353 |doi=10.4103/2152-7806.169561 |url=}}</ref> | ||
| style="background:#F5F5F5;" align="center" + |>35 | | style="background:#F5F5F5;" align="center" + |>35 | ||
Line 392: | Line 391: | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Electromyogram | ! style="background:#4479BA; color: #FFFFFF;" align="center" + |Electromyogram | ||
|- | |- | ||
! rowspan="2" style="background:# | ! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Neuromuscular | ||
! style="background:#DCDCDC;" align="center" + |[[Botulinum]]<ref name="pmid15257512">{{cite journal |vauthors=Cherington M |title=Botulism: update and review |journal=Semin Neurol |volume=24 |issue=2 |pages=155–63 |date=June 2004 |pmid=15257512 |doi=10.1055/s-2004-830901 |url=}}</ref> | ! style="background:#DCDCDC;" align="center" + |[[Botulinum]]<ref name="pmid15257512">{{cite journal |vauthors=Cherington M |title=Botulism: update and review |journal=Semin Neurol |volume=24 |issue=2 |pages=155–63 |date=June 2004 |pmid=15257512 |doi=10.1055/s-2004-830901 |url=}}</ref> | ||
| style="background:#F5F5F5;" align="center" + |Variable | | style="background:#F5F5F5;" align="center" + |Variable |
Revision as of 18:24, 6 August 2018
Differential diagnosis of distal muscle weakness:
Organ system | Disease | Symptoms | History | Physical
Examination |
Diagnosis | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Age of onset | Muscle weakness | Fever | Myalgia | Contractures | Gait abnormality | Neuropathy | Atrophy | Stiffness | Myoglobinuria | Other features | Laboratory Findings | Creatine Kinase | Muscle Biopsy | Electromyogram | |||||
Endocrine | Hyperaldosteronism with myopathy[1] | 50 | Proximal & distal |
− | − | − | − | − | − | − | + |
|
|
|
| ||||
Inflammatory/ Rheumatologic | Inclusion body myositis[2] | 50s | Proximal & distal |
− | − | − | − | − | − | − | − |
|
|
|
|
|
|
||
Fibromyalgia[3] | 40−50s | Generalized | − | − | − | − | + | − | − | − |
|
|
|
|
|
|
| ||
Polymyalgia Rheumatica[4] | 50s | Diffuse | + | + | − | − | − | − | + | − |
|
|
|
|
| ||||
Genetic | Myotonic dystrophy[5] | <18 years | Proximal & distal |
− | − | + | + | − | − | + | − |
|
|
|
|
|
|
||
Organ system | Disease | Age of onset | Muscle weakness | Fever | Myalgia | Contractures | Gait abnormality | Neuropathy | Atrophy | Stiffness | Myoglobinuria | Other features | History | Physical
Examination |
Laboratory Findings | Creatine Kinase | Muscle Biopsy | Electromyogram | |
Infectious | Influenza[6] | Variable | Proximal and Distal | + | + | − | + | − | − | − | + |
|
|
|
|
|
|
| |
Pyomyositis[7] | Variable | Proximal & Distal |
+ | + | − | − | − | − | + | − |
|
|
|
|
| ||||
Organ system | Disease | Age of onset | Muscle weakness | Fever | Myalgia | Contractures | Gait abnormality | Neuropathy | Atrophy | Stiffness | Myoglobinuria | Other features | History | Physical
Examination |
Laboratory Findings | Creatine Kinase | Muscle Biopsy | Electromyogram | |
Neurologic | ALS[8] | >35 | Proximal & Distal |
− | − | − | − | + | + | + | − |
|
|
|
|
|
| ||
Stroke[9] | >65 | Proximal & distal |
− | − | − | + | + | + | − | − |
|
|
|
|
|
|
| ||
Multiple Sclerosis[10] | 30's | Proximal & distal |
− | − | − | + | + | − | − | − |
|
|
|
|
|
|
| ||
Organ system | Disease | Age of onset | Muscle weakness | Fever | Myalgia | Contractures | Gait abnormality | Neuropathy | Atrophy | Stiffness | Myoglobinuria | Other features | History | Physical
Examination |
Laboratory Findings | Creatine Kinase | Muscle Biopsy | Electromyogram | |
Neuromuscular | Botulinum[11] | Variable | Distal | − | − | − | + | − | − | + | − |
|
|
|
|
|
|
| |
Lambert−Eaton syndrome[12] | Variable | Distal | − | − | + | + | − | − | + | − |
|
|
|
- ↑ Sambrook MA, Heron JR, Aber GM (April 1972). "Myopathy in association with primary hyperaldosteronism". J. Neurol. Neurosurg. Psychiatry. 35 (2): 202–7. PMC 494037. PMID 5037033.
- ↑ Dalakas MC (1991). "Polymyositis, dermatomyositis and inclusion-body myositis". N Engl J Med. 325 (21): 1487–98. doi:10.1056/NEJM199111213252107. PMID 1658649.
- ↑ Ohara N, Katada S, Yamada T, Mezaki N, Suzuki H, Suzuki A, Hanyu O, Yoneoka Y, Kawachi I, Shimohata T, Kakita A, Nishizawa M, Sone H (2016). "Fibromyalgia in a Patient with Cushing's Disease Accompanied by Central Hypothyroidism". Intern. Med. 55 (21): 3185–3190. doi:10.2169/internalmedicine.55.5926. PMC 5140872. PMID 27803417.
- ↑ Myklebust G, Gran JT (1996). "A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis". Br J Rheumatol. 35 (11): 1161–8. PMID 8948307.
- ↑ Udd B, Krahe R (October 2012). "The myotonic dystrophies: molecular, clinical, and therapeutic challenges". Lancet Neurol. 11 (10): 891–905. doi:10.1016/S1474-4422(12)70204-1. PMID 22995693.
- ↑ Bove KE, Hilton PK, Partin J, Farrell MK (1983). "Morphology of acute myopathy associated with influenza B infection". Pediatr Pathol. 1 (1): 51–66. PMID 6687269.
- ↑ Crum NF (September 2004). "Bacterial pyomyositis in the United States". Am. J. Med. 117 (6): 420–8. doi:10.1016/j.amjmed.2004.03.031. PMID 15380499.
- ↑ Zarei S, Carr K, Reiley L, Diaz K, Guerra O, Altamirano PF, Pagani W, Lodin D, Orozco G, Chinea A (2015). "A comprehensive review of amyotrophic lateral sclerosis". Surg Neurol Int. 6: 171. doi:10.4103/2152-7806.169561. PMC 4653353. PMID 26629397.
- ↑ Baldwin K, Orr S, Briand M, Piazza C, Veydt A, McCoy S (May 2010). "Acute ischemic stroke update". Pharmacotherapy. 30 (5): 493–514. doi:10.1592/phco.30.5.493. PMID 20412000.
- ↑ Goldenberg MM (March 2012). "Multiple sclerosis review". P T. 37 (3): 175–84. PMC 3351877. PMID 22605909.
- ↑ Cherington M (June 2004). "Botulism: update and review". Semin Neurol. 24 (2): 155–63. doi:10.1055/s-2004-830901. PMID 15257512.
- ↑ Titulaer MJ, Lang B, Verschuuren JJ (December 2011). "Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies". Lancet Neurol. 10 (12): 1098–107. doi:10.1016/S1474-4422(11)70245-9. PMID 22094130.